GENENTECH, INC for GENENTECH INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 19, 2010 | $1,070,000 | Replaced |
| 1st Quarter - Amendment | Apr 20, 2010 | $1,120,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of HR1 Medicare Prescription Drug and Modernization Act of 2003 Issues relating to PDUFA, stimulus
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Copyright/Patent/Trademark CPT
H.R. 1908 Intellectual Property and Process Patent Issues S. 515 & H.R. 1260 - Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Health Issues HCR
Physician payment disclosure including S.301 Physician Payments Sunshine Act of 2009 H.R. 3962, Affordable health Care for Americans Act H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, the Reconciliation Act of 2010 Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act S. 726/H.R. 1427, Promoting Innovationo and Access to Life Saving Medicines Act H.R. 3962, Affordable Health Care for America Act Comparative effectiveness legislation including S. 1213 Patient-Centered Outcomes Research Act of 2009 H.R. 3200, America's Health Future Act H.R. 1548 - Pathway for Dissimilar Act Legislative changes in the health care reform bill regarding dissimilar Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act." Pandemic Preparedness - Tamiflu Exploring additional funding for antiviral stockpiling in response to H1N1 and H5N1 Pandemic Influenza H.R. 1105 - omnibus Appropriations Act FY10 labor HHS Appropriations Legislation H.R. 1105 - Omnibus Appropriations Act FY10 Labor HHS Appropriations legislation H.R. 2346 supplemental Appropriations Act of 2009 FY11 Labor, HHS and Education Appropriates related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment FY11 State Foreign Operations Appropriations related to USAID and funding for pandemic influenza H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 Ryan White CARE Act reauthorization S. 1679, Affordable Health Choices Act S. 1796, America's Healthy Future Act of 2009 Pharmaceutical import safety legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Budget/Appropriations BUD
Issues relating to government purchases and stockpiling of pandemic drugs - Tamiflu
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Food Industry (safety, labeling, etc.) FOO
Monitor food safety and supply chain issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Homeland Security HOM
Labor HHS Appropriations - S. 3230 and H.R. 3042 Homeland Security Appropriations S.3181 and H.R. 6947
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Medical/Disease Research/Clinical Labs MED
S. 565/H.R. 1458 - providing extended coverage for immunosuppressive drugs to beneficiaries under ther Medicare Program that have received a kidney transplant
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Trade (domestic/foreign) TRD
Monitor issues related to export rules and regulations International patent issues WTO matters and other international trade issues impacting biotech and pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Taxation/Internal Revenue Code TAX
Monitoring proposals on U.S. tax treatment of foreign corporations S. 506, Stop Tax Haven Abuse Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.